Back
Novonesis AS Quote, Financials, Valuation and Earnings
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
45
NVZMY
Novonesis AS
Last Price:
55.22
Seasonality Move:
4.56%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.Novonesis AS Price Quote
$55.22
+0.09 (+0.16%)
(Updated: May 1, 2024 at 11:50 AM ET)
Novonesis AS Key Stats
Sell
45
Novonesis AS (NVZMY)
is a Sell
Day range:
$55.13 - $56.28
52-week range:
$38.75 - $61.86
Dividend yield:
2.62%
P/E ratio:
34.90
P/S ratio:
5.90
P/B ratio:
12.34%
Volume:
6.8K
Avg. volume:
10.1K
1-year change:
6.02%
Market cap:
$25.6B
Revenue:
$2.6B
EPS:
$1.58
How Much Does Novonesis AS Make?
-
How Much Are Novonesis AS's Sales Annually?
NVZMY Revenues are $2.6B -
How Much Profit Does Novonesis AS's Make A Year?
NVZMY net income is $439M
Is Novonesis AS Growing As A Company?
-
What Is Novonesis AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is Novonesis AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.17%
Novonesis AS Stock Price Performance
-
Did Novonesis AS Stock Go Up Last Month?
Novonesis AS share price went down by -6.34% last month -
Did NVZMY's Share Price Rise Over The Last Year?
NVZMY share price rose by 6.02% over the past 1 year
What Is Novonesis AS 52-Week High & Low?
-
What Is Novonesis AS’s 52-Week High Share Price?
Novonesis AS has traded as high as $61.86 over the past 52 weeks -
What Is Novonesis AS’s 52-Week Low Share Price?
Novonesis AS has traded as low as $38.75 over the past 52 weeks
Novonesis AS Price To Free Cash Flow
-
Is Novonesis AS Stock Overvalued?
Novonesis AS is trading at a price to free cash flow ratio of 50.35 -
Is Novonesis AS Stock Undervalued?
Novonesis AS EV to Free Cash Flow ratio is 87.34 -
What Is Novonesis AS’s Price Earnings Growth Ratio?
NVZMY PEG ratio is 0.00 -
Is Novonesis AS Trading At A Premium To Earnings?
Novonesis AS EV to EBIT ratio is 42.96
Is It Risky To Buy Novonesis AS?
-
How Much Debt Does Novonesis AS Have?
Total long term debt quarterly is $1.1B -
How Much Cash Does Novonesis AS Have?
Cash and short term investments quarterly total is $171.6M -
What Is Novonesis AS’s Book Value Per Share?
Book value per share is 7.48
Is Novonesis AS Cash Flow Positive?
-
What Is NVZMY Cash Flow From Operations?
Cash flow from operations (TTM) is $602.8M -
What Is Novonesis AS’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$274.3M -
What Is Novonesis AS’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$309.7M
Novonesis AS Return On Invested Capital
-
Is Management Doing A Good Job?
NVZMY return on invested capital is 17.9% -
What Is Novonesis AS Return On Assets?
ROA measures how assets are converting to revenues and is 10.69% -
What Is NVZMY Return On Equity?
ROE is a measure of profitability and is 21.43%
Novonesis AS Earnings Date & Stock Price
-
What Is Novonesis AS's Stock Price Today?
A single share of NVZMY can be purchased today for 55.13 -
What Is Novonesis AS’s Stock Symbol?
Novonesis AS trades on the otcm under the ticker symbol: NVZMY -
When Is Novonesis AS’s Next Earnings Date?
The next quarterly earnings date for Novonesis AS is scheduled on May 3, 2024 -
When Is NVZMY's next ex-dividend date?
Novonesis AS's next ex-dividend date is May 1, 2024 -
How To Buy Novonesis AS Stock?
You can buy Novonesis AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novonesis AS Competitors
-
Who Are Novonesis AS's Competitors?
Below is a list of companies who compete with Novonesis AS or are related in some way:
Novonesis AS Dividend Yield
-
What Is NVZMY Dividend Yield?
Novonesis AS’s dividend yield currently is 2.62% -
What Is Novonesis AS’s Payout Ratio?
Novonesis AS’s payout ratio is 94.44% -
When Did Novonesis AS Last Pay A Dividend?
The latest dividend pay date is May 1, 2024 -
What Is Novonesis AS’s Dividend Per Share?
Novonesis AS pays a dividend of $0.60 per share
Novonesis AS Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -17.14% | 0% |
| Revenue: | 6.7% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |